The health data landscape is evolving rapidly across the globe. The effective and fair use of health data is key to unlocking scientific innovation in the life sciences sector, developing AI-based technologies and improving healthcare for patients and the public. Changes in data protection law and guidance, including the proposals for the European Health Data Space, offer both opportunities and challenges to health and life sciences businesses and technology providers. This webinar will look at recent and proposed changes in law and guidance and answer the most important questions raised by the sector as it navigates these developments.
Join our McDermott Will and Emery team for this webinar where our experts on health and life sciences data will discuss:
- Overview of the current regulatory landscape and proposed changes in the EU and UK
- Key issues on the use and sharing of health and life sciences data
- Enforcement trends
- Avoiding common pitfalls when dealing with health data
Speakers
Sharon Lamb
Partner
McDermott Will & Emery
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector.
Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies.
Sharon also provides strategic, regulatory and commercial support to UK and international clients on UK health and life sciences with a focus on health services, pharmaceuticals, medical devices, digital health and health data. Sharon is widely recognized for her expertise on NHS and public law regulatory and contracting matters, including payment and reimbursement and market access.
Deniz Tschammler
Partner
McDermott Will & Emery
Deniz specializes on complex legal, commercial and strategic projects in the health and life sciences sector. He advises on transactions and collaborations, disputes in and out of court, market entry and reimbursement pathways, as well as data protection and other compliance challenges of an increasingly digitized industry. His clients involve global pharmaceutical companies and medical device manufacturers, early stage companies with a focus on innovative health products and disruptive business models, as well as investors in German and European health markets.
Lorraine Maisnier-Boché
Associate
McDermott Will & Emery
Lorraine Maisnier-Boché focuses her practice on data protection and information technology (IT) law.
She has deep experience in the digital and IT sector as well as the health care industry, frequently advising health care professionals, hospitals, governmental entities, insurance companies, medical device manufacturers, software editors and hosting service providers on complex IT projects.
Lorraine has a strong background in data protection, and regularly advises on GDPR compliance programs, international data transfers, marketing and profiling actions, sensitive data (e.g., personal health data), audits and security issues.
Daniel Gottlieb
Partner
McDermott Will & Emery
Daniel Gottlieb counsels a wide range of healthcare industry clients, including healthcare providers, health plans, health information technology vendors, life sciences companies and data aggregators. He is sought out for his legal knowledge and practical approach on data protection, interoperability, and complex data and software licensing transactions, collaborations and strategic initiatives.
Daniel counsels healthcare clients regarding compliance with US federal and state and international privacy, security, breach notification and information blocking laws, including the Health Insurance Portability and Accountability Act (HIPAA), 21st Century Cures Act, California Consumer Privacy Act (CCPA), Telephone Consumer Protection Act, CAN-SPAM and EU General Data Protection Regulation (GDPR).
